Connection

Michael Lilly to Combined Modality Therapy

Back to Details
This is a "connection" page, showing publications Michael Lilly has written about Combined Modality Therapy.
Michael Lilly
Connection Strength
0.033
Combined Modality Therapy
  1. Advanced glycation end products are elevated in estrogen receptor-positive breast cancer patients, alter response to therapy, and can be targeted by lifestyle intervention. Breast Cancer Res Treat. 2019 Feb; 173(3):559-571.
    View in: PubMed
    Score: 0.033
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.